Elanco

Elanco is a global animal health company committed to enhancing the well-being and health of animals worldwide. Established in 1954, the company focuses on delivering innovative products and services for both pets and farm animals. With the core belief that healthier animals make for a better life, Elanco strives to empower veterinarians and farmers with the necessary tools to ensure the well-being of animals.

The company's last investment of $250.00M in post-IPO equity, received on 30 December 2023 from Ancora, reflects investor confidence in Elanco's business model and potential for growth in the Biotechnology, Health Care, and Pharmaceutical sectors.

Embracing a holistic approach, Elanco is dedicated to its Elanco Healthy Purpose™ framework, encompassing environmental, social, and governance (ESG) commitments. This program not only emphasizes the development of sustainable solutions but also encourages employees worldwide to contribute as volunteers, further strengthening the company's impact on society.

With its headquarters in the United States, Elanco emphasizes its commitment to advancing a vision of Food and Companionship Enriching Life, underlining its aspiration to be a unique force for good, benefiting animals, people, and the planet.

Overall, Elanco's dedication to enhancing animal health, coupled with its recent substantial investment and focus on sustainable solutions, positions the company attractively for potential investors seeking exposure to the burgeoning animal health and biotechnology industries.